NIH-funded research R21 grant

Precision risk tools for blood clots and bleeding in critically ill children

Official title: Secondary Analysis of the Children's Healthcare Advancements in Thrombosis (CHAT) Consortium Dataset

Funded at University of California, San Diego · NIH-11445625 · Data updated 2026-11-12

A pediatric-focused project will use existing data from many hospitals to build and test a risk model that helps doctors decide which very sick kids might benefit from clot-prevention therapies.

More Thrombosis research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego
NIH-funded
Lab location1 site (La Jolla, United States)
Project startAugust 1, 2026
Project endJuly 31, 2028
Funding year2026
Award (this year)$189,000
NIH project number1R21HL181655-01A1
Project IDNIH-11445625 on NIH RePORTER

Who could benefit from this research

Could help

Critically ill children admitted to pediatric ICUs at participating CHAT centers with available clinical and laboratory data.

Less likely to help

Children outside ICU settings or without high risk factors may not see a direct benefit from these risk models.

What this research studies

This project analyzes a large dataset of over 4,600 children admitted to pediatric ICUs to create risk scores for venous thromboembolism and bleeding. By identifying the worst-affected patterns and key lab and clinical factors, clinicians could tailor prevention strategies to each child. The work uses secondary analysis of existing CHAT data to build and validate the models, aiming to guide safer care for high-risk pediatric patients. It seeks to provide practical tools that could be used in real clinical settings to balance thrombosis risk with bleeding risk.

Why it matters

Potential benefit: If successful, clinicians could more accurately identify which children need thromboprophylaxis, potentially reducing blood clots while minimizing bleeding risks.

How similar studies have gone: Prior pediatric VTE studies show promise for risk-based approaches, but this project emphasizes a validated RAM using a large, multicenter dataset.

Where this research is happening

  • University of California, San Diego
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Jaffray, Julie Ann — University of California, San Diego
  • Study coordinator: Jaffray, Julie Ann

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.